Decision for Safe Discharge After Gastric Cancer Surgery: The Finale of Enhanced Recovery After Surgery Program.

IF 3.2 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Journal of Gastric Cancer Pub Date : 2022-10-01 DOI:10.5230/jgc.2022.22.e34
Yoon Young Choi
{"title":"Decision for Safe Discharge After Gastric Cancer Surgery: The Finale of Enhanced Recovery After Surgery Program.","authors":"Yoon Young Choi","doi":"10.5230/jgc.2022.22.e34","DOIUrl":null,"url":null,"abstract":"https://jgc-online.org Since the first successful gastrectomy by Theodor Billroth in 1881 [1], surgery has been the main treatment option for gastric cancer, which is one of the main causes of death in the Republic of Korea [2]. Understanding the biology of cancer and anatomy of the stomach and surrounding structures [3], the developed surgical technique and equipment [4], and improved perioperative care [5] help improve the surgical outcomes after gastrectomy for gastric cancer. The related mortality has dramatically decreased from 69% in the 1880s to less than 1% recently [1,6]. The hospital stay has also decreased from 22 days reported in the first cases by Billroth to 7 days in recent cases [6], and the minimally invasive surgery reduced it to even less than 5 days [7]. The enhanced recovery after surgery (ERAS), a multimodal, multidisciplinary approach to surgical treatment, is the center of this improvement.","PeriodicalId":56072,"journal":{"name":"Journal of Gastric Cancer","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f9/fa/jgc-22-261.PMC9633927.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastric Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5230/jgc.2022.22.e34","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

https://jgc-online.org Since the first successful gastrectomy by Theodor Billroth in 1881 [1], surgery has been the main treatment option for gastric cancer, which is one of the main causes of death in the Republic of Korea [2]. Understanding the biology of cancer and anatomy of the stomach and surrounding structures [3], the developed surgical technique and equipment [4], and improved perioperative care [5] help improve the surgical outcomes after gastrectomy for gastric cancer. The related mortality has dramatically decreased from 69% in the 1880s to less than 1% recently [1,6]. The hospital stay has also decreased from 22 days reported in the first cases by Billroth to 7 days in recent cases [6], and the minimally invasive surgery reduced it to even less than 5 days [7]. The enhanced recovery after surgery (ERAS), a multimodal, multidisciplinary approach to surgical treatment, is the center of this improvement.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胃癌手术后安全出院的决定:增强术后恢复计划的结局。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Gastric Cancer
Journal of Gastric Cancer Biochemistry, Genetics and Molecular Biology-Cancer Research
CiteScore
4.30
自引率
12.00%
发文量
36
期刊介绍: The Journal of Gastric Cancer (J Gastric Cancer) is an international peer-reviewed journal. Each issue carries high quality clinical and translational researches on gastric neoplasms. Editorial Board of J Gastric Cancer publishes original articles on pathophysiology, molecular oncology, diagnosis, treatment, and prevention of gastric cancer as well as articles on dietary control and improving the quality of life for gastric cancer patients. J Gastric Cancer includes case reports, review articles, how I do it articles, editorials, and letters to the editor.
期刊最新文献
Textbook Outcome of Delta-Shaped Anastomosis in Minimally Invasive Distal Gastrectomy for Gastric Cancer in 4,505 Consecutive Patients. The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences. Characteristics of Metachronous Remnant Gastric Cancer After Proximal Gastrectomy: A Retrospective Analysis. Diffuse-Type Histology Is Prognostic for All Siewert Types of Gastroesophageal Adenocarcinoma. Efficacy of Hyperthermic Pressurized Intraperitoneal Aerosol Chemotherapy in an In Vitro Model Using a Human Gastric Cancer AGS Cell Line and an Abdominal Cavity Model.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1